NEOVII Biotech GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 2003-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.neovii.com
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
5
NMPA:4
CIMA_AEMPS:1
Drug Approvals
Anti-human T Lymphocyte Rabbit Immunoglobulin
- Product Name
- Grafalon
- Approval Number
- 国药准字SJ20150058
- Approval Date
- Apr 2, 2024
NMPA
Anti-human T Lymphocyte Rabbit Immunoglobulin
- Product Name
- 抗人T细胞兔免疫球蛋白
- Approval Number
- 国药准字J20150042
- Approval Date
- Nov 28, 2019
NMPA
Anti-human T Lymphocyte Rabbit Immunoglobulin
- Product Name
- Grafalon
- Approval Number
- S20150059
- Approval Date
- Sep 23, 2019
NMPA
Anti-human T Lymphocyte Rabbit Immunoglobulin
- Product Name
- Grafalon
- Approval Number
- S20150058
- Approval Date
- Sep 23, 2019
NMPA
Clinical Trials
No trials found
News
No news found